Related references
Note: Only part of the references are listed.Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment
David A. Wheeler et al.
CANCER CELL (2021)
Transcriptome analysis of fetal rat testis following intrauterine exposure to the azole fungicides triticonazole and flusilazole reveals subtle changes despite adverse endocrine effects
Monica Kam Draskau et al.
CHEMOSPHERE (2021)
Recent Advances in Microfluidic Platforms Applied in Cancer Metastasis: Circulating Tumor Cells' (CTCs) Isolation and Tumor-On-A-Chip
Zhengjie Lin et al.
SMALL (2020)
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma
Caroline Roelants et al.
CANCERS (2020)
IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia
Chunhua Song et al.
BLOOD (2020)
The multifaceted role of reactive oxygen species in tumorigenesis
Anuradha Kirtonia et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Protein Kinase CK2 in Cancer Energetics
Eduardo Silva-Pavez et al.
FRONTIERS IN ONCOLOGY (2020)
Kinase Interaction Network Expands Functional and Disease Roles of Human Kinases
Marija Buljan et al.
MOLECULAR CELL (2020)
Targeting the HIF2-VEGF axis in renal cell carcinoma
Toni K. Choueiri et al.
NATURE MEDICINE (2020)
Role of Protein Kinase CK2 in Aberrant Lipid Metabolism in Cancer
Barbara Guerra et al.
PHARMACEUTICALS (2020)
Protein kinase CK2 and ion channels (Review)
Mathias Montenarh et al.
BIOMEDICAL REPORTS (2020)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
Xenograft and organoid model systems in cancer research
Margit Bleijs et al.
EMBO JOURNAL (2019)
Role of protein kinase CK2 in antitumor drug resistance
Christian Borgo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
ROS and the DNA damage response in cancer
Upadhyayula Sai Srinivas et al.
REDOX BIOLOGY (2019)
BRB-seq: ultra-affordable high-throughput transcriptomics enabled by bulk RNA barcoding and sequencing
Daniel Alpern et al.
GENOME BIOLOGY (2019)
Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma
Roelants Caroline et al.
Oncotarget (2018)
MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites
Sugiko Watanabe et al.
SCIENTIFIC REPORTS (2018)
WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies
Anne Y. Warren et al.
WORLD JOURNAL OF UROLOGY (2018)
New horizons in hypoxia signaling pathways
Christopher W. Pugh et al.
EXPERIMENTAL CELL RESEARCH (2017)
Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma
Bernhard Gillissen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Andrew N. Blackford et al.
MOLECULAR CELL (2017)
Chemical screening identifies ATM as a target for alleviating senescence
Hyun Tae Kang et al.
NATURE CHEMICAL BIOLOGY (2017)
Targeted therapies for renal cell carcinoma
Edwin M. Posadas et al.
NATURE REVIEWS NEPHROLOGY (2017)
Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
Hanna-Riikka Teppo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival
Jordi Vilardell et al.
Oncotarget (2017)
Trefoil factor 3 contributes to the malignancy of glioma via regulating HIF-1 alpha
Shuo Diao et al.
ONCOTARGET (2017)
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Melissa M. J. Chua et al.
PHARMACEUTICALS (2017)
Casein kinases as potential therapeutic targets
Giorgio Cozza et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Molecular mechanisms of ROS production and oxidative stress in diabetes
Philip Newsholme et al.
BIOCHEMICAL JOURNAL (2016)
Activation of apoptosis signalling pathways by reactive oxygen species
Maureen Redza-Dutordoir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Targeting HIF2α in Clear-Cell Renal Cell Carcinoma
Christopher J. Ricketts et al.
CANCER CELL (2016)
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Eli M. Wallace et al.
CANCER RESEARCH (2016)
The DNA damage-induced cell death response: a roadmap to kill cancer cells
Sonja Matt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells
Adam J. Rabalski et al.
CLINICAL CANCER RESEARCH (2016)
Targeting renal cell carcinoma with a HIF-2 antagonist
Wenfang Chen et al.
NATURE (2016)
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho et al.
NATURE (2016)
ROS homeostasis and metabolism: a dangerous liason in cancer cells
E. Panieri et al.
CELL DEATH & DISEASE (2016)
5d, a novel analogue of 3-n-butylphthalide, decreases NADPH oxidase activity through the positive regulation of CK2 after ischemia/reperfusion injury
Jia Zhou et al.
ONCOTARGET (2016)
Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions
Geou-Yarh Liou et al.
CELL REPORTS (2016)
The von Hippel-Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform
F. Chesnel et al.
BRITISH JOURNAL OF CANCER (2015)
MEK Inhibitor PD-0325901 Overcomes Resistance to CK2 Inhibitor CX-4945 and Exhibits Anti-Tumor Activity in Head and Neck Cancer
Yansong Bian et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Regulation of Hypoxia-Inducible Factor-1a by Reactive Oxygen Species : New Developments in an Old Debate
Shahrzad Movafagh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Targeting cancer with kinase inhibitors
Stefan Gross et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Oxidative stress inhibits distant metastasis by human melanoma cells
Elena Piskounova et al.
NATURE (2015)
ATM and ATR as therapeutic targets in cancer
Anika Maria Weber et al.
PHARMACOLOGY & THERAPEUTICS (2015)
NADPH oxidase 4 is a critical mediator in Ataxia telangiectasia disease
Urbain Weyemi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Therapeutic opportunities within the DNA damage response
Laurence H. Pearl et al.
NATURE REVIEWS CANCER (2015)
The role of oxidized ATM in the regulation of oxidative stress-induced energy metabolism reprogramming of CAFs
Shifu Tang et al.
CANCER LETTERS (2014)
NADPH Oxidase NOX4 Supports Renal Tumorigenesis by Promoting the Expression and Nuclear Accumulation of HIF2α
Jennifer L. Gregg et al.
CANCER RESEARCH (2014)
Transcriptional regulation by hypoxia inducible factors
Veronica L. Dengler et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Protein Kinase CK2 Inhibition Induces Cell Death via Early Impact on Mitochondrial Function
Fatima Qaiser et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Phosphoproteomics of MAPK Inhibition in BRAF-Mutated Cells and a Role for the Lethal Synergism of Dual BRAF and CK2 Inhibition
Robert Parker et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia
L. R. Martins et al.
LEUKEMIA (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
ATM signalling and cancer
C. A. Cremona et al.
ONCOGENE (2014)
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A. Mathews Griner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Treacher Collins syndrome TCOF1 protein cooperates with NBS1 in the DNA damage response
Alberto Ciccia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Activation of DNA Damage Response Signaling by Condensed Chromatin
Rebecca C. Burgess et al.
CELL REPORTS (2014)
Hydrogen peroxide sensing, signaling and regulation of transcription factors
H. Susana Marinho et al.
REDOX BIOLOGY (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Chromatin Remodeling at DNA Double-Strand Breaks
Brendan D. Price et al.
CELL (2013)
Rechallenge with mTOR Inhibitors in Metastatic Renal Cell Carcinoma Patients Who Progressed on Previous mTOR Inhibitor Therapy
Agnes Maj-Hes et al.
ONCOLOGY (2013)
Mitochondrial Genome Instability and ROS Enhance Intestinal Tumorigenesis in APCMin/+ Mice
Dong Kyun Woo et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells
Joshua Bliesath et al.
CANCER LETTERS (2012)
Oxidative stress induces an ATM-independent senescence pathway through p38 MAPK-mediated lamin B1 accumulation
Aurelia Barascu et al.
EMBO JOURNAL (2012)
Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription
Hilal S. Khalil et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy
Razmik Mirzayans et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target
Marco Gerlinger et al.
JOURNAL OF PATHOLOGY (2012)
Novel Agents and Approaches for Advanced Renal Cell Carcinoma
Robert Figlin et al.
JOURNAL OF UROLOGY (2012)
CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy
Adam Siddiqui-Jain et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator
Stephanie Jungmichel et al.
NUCLEIC ACIDS RESEARCH (2012)
A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
S. Sivanand et al.
Science Translational Medicine (2012)
Findings from the phase I clinical trials of CX-4945, an orally available inhibitor of CK2.
R. F. Marschke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
Fabrice Pierre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma
Blanka Kucejova et al.
MOLECULAR CANCER RESEARCH (2011)
A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer
Markus K. Muellner et al.
NATURE CHEMICAL BIOLOGY (2011)
Genetic and Functional Studies Implicate HIF1α as a 14q Kidney Cancer Suppressor Gene
Chuan Shen et al.
CANCER DISCOVERY (2011)
Addiction to protein kinase CK2: A common denominator of diverse cancer cells?
Maria Ruzzene et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
ATM activation in the presence of oxidative stress
Zhi Guo et al.
CELL CYCLE (2010)
Multicellular tumor spheroids: An underestimated tool is catching up again
Franziska Hirschhaeuser et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Cora N. Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
Valentina Vaira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Synthetic Lethal Screen of an EGFR-Centered Network to Improve Targeted Therapies
Igor Astsaturov et al.
SCIENCE SIGNALING (2010)
Emerging Evidence for the Importance of Phosphorylation in the Regulation of NADPH Oxidases
Gary M. Bokoch et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
CK2: A key player in cancer biology
J. H. Trembley et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites
Sairei So et al.
JOURNAL OF CELL BIOLOGY (2009)
Resistance to targeted therapy in renal-cell carcinoma
Brian I. Rini et al.
LANCET ONCOLOGY (2009)
HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses
Jessica A. Bertout et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2
James S. Duncan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells
Seung-Nam Jung et al.
CARCINOGENESIS (2008)
Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau
Andrew M. Roberts et al.
CURRENT OPINION IN ONCOLOGY (2008)
Combination chemical genetics
Joseph Lehar et al.
NATURE CHEMICAL BIOLOGY (2008)
The regulatory β-subunit of protein kinase CK2 regulates cell-cycle progression at the onset of mitosis
C. W. Yde et al.
ONCOGENE (2008)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
HIRIP3 is a nuclear phosphoprotein interacting with and phosphorylated by the serine-threonine kinase CK2
Nadine Assrir et al.
BIOLOGICAL CHEMISTRY (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Role for casein kinase 2 in the regulation of HIF-1 activity
D Mottet et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis
A Kurose et al.
CYTOMETRY PART A (2005)
Nox4 is critical for hypoxia-inducible factor 2-α transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma
JK Maranchie et al.
CANCER RESEARCH (2005)
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma
DF McDermott et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Nox enzymes and the biology of reactive oxygen
JD Lambeth
NATURE REVIEWS IMMUNOLOGY (2004)
Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK
F Kappes et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activity
DE Lancaster et al.
BIOCHEMICAL JOURNAL (2004)
Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL
P Staller et al.
NATURE (2003)
Modeling tissue-specific signaling and organ function in three dimensions
KL Schmeichel et al.
JOURNAL OF CELL SCIENCE (2003)
ATM and related protein kinases: Safeguarding genome integrity
Y Shiloh
NATURE REVIEWS CANCER (2003)
Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids
W Günther et al.
BRITISH JOURNAL OF CANCER (2003)
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
DW Litchfield
BIOCHEMICAL JOURNAL (2003)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
Protein kinase CK2: a challenge to canons
LA Pinna
JOURNAL OF CELL SCIENCE (2002)
Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma
S Ashida et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Molecular basis of the VHL hereditary cancer syndrome
WG Kaelin
NATURE REVIEWS CANCER (2002)
The transcriptional activation function of the HIF-like factor requires phosphorylation at a conserved threonine
K Gradin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Spheroids in radiobiology and photodynamic therapy
C Dubessy et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
Identification of Renox, an NAD(P)H oxidase in kidney
M Geiszt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
